我院应用胰高糖素-胰岛素疗法(以下称G-I疗法)治疗各型重型肝炎50例,现结合临床资料及其中15例患者血胰高糖素、胰岛素检测结果,对其疗效分析如下: 全部病例均为住院患者,诊断均符合984年全国肝炎学术会议制定的重型肝炎(包括慢性活动型肝炎重型,以下称慢活肝重型)诊断标准。男41例,女9例;<13岁者1例,13～50岁36例,50岁以上者13例,最大者70岁,HBV感染率为98%。存活20例(40%)死亡30例(60%),急性重型肝炎3例,均存活;其中亚急性重型肝炎病死 Our hospital application of glucagon - insulin therapy (hereinafter referred to as GI therapy) for the treatment of 50 cases of various types of severe hepatitis, are now combined with clinical data and 15 cases of patients with blood glucagon and insulin test results, the analysis of its efficacy as follows: All All cases were hospitalized patients, the diagnosis is in line with the 984 National Hepatology Conference developed severe hepatitis (including chronic active hepatitis, severe, hereinafter referred to as slow-living liver) diagnostic criteria. There were 41 males and 9 females. One patient under 13 years old, 36 patients aged 13 to 50 years and 13 patients over 50 years old, the largest was 70 years old and the rate of HBV infection was 98%. Survival of 20 patients (40%) died of 30 cases (60%), 3 cases of acute severe hepatitis, all survived; of which sub-acute severe hepatitis died